Hagino, H., Yoshida, S., Hashimoto, J., Matsunaga, M., Tobinai, M., & Nakamura, T. (2014). Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study. Calcif Tissue Int.

Hagino, Hiroshi, Seitaro Yoshida, Junko Hashimoto, Masayuki Matsunaga, Masato Tobinai, and Toshitaka Nakamura. "Increased Bone Mineral Density With Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients With Primary Osteoporosis: Three-Year Analysis of the MOVER Study." Calcif Tissue Int 2014.

Hagino, Hiroshi, et al. "Increased Bone Mineral Density With Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients With Primary Osteoporosis: Three-Year Analysis of the MOVER Study." Calcif Tissue Int 2014.